Aptar Pharma

http://www.aptar.com/pharma
More from Aptar Pharma
Marcus Bates, Aptar
A Pharmapack Europe 2022 Preview: The Future of Medical Devices
Healthcare Packaging speaks with Marcus Bates, vice president, global business development, Aptar Digital Health, on what lies ahead for the digital therapy and devices field.
May 16th, 2022
Mumford Unisafe
Noble International and Owen Mumford Collaborating on Patient Training Solutions
Noble will develop and provide training programs and materials to support and educate patients on Owen Mumford injection devices, with the aim of improving therapy adherence and patient confidence.
Apr 1st, 2022
Aptar Hero Tracker
Aptar Pharma MDI Add-on Device Aids in Patient Inhalation Technique
Turns a standard metered dose inhaler into a connected device
Feb 18th, 2022
Ryaltris is a metered, fixed-dose, aqueous suspension prescription combination drug product nasal spray for allergy treatment.
Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA
Glenmark’s Ryaltris nasal spray, using Aptar Pharma’s VP3 nasal spray system, treats nasal and ocular symptoms.
Feb 17th, 2022
This collaboration will initially focus on bringing together connected drug delivery devices and the digital platform for asthma and chronic obstructive pulmonary disease (COPD).
Aptar and Sonmol Partner to Develop Digital Platform for Respiratory-Related Therapies
Collaboration also includes strategic investment by Aptar Pharma; will develop digital therapies and services targeting respiratory diseases.
Apr 24th, 2020
3-phase Activ-Polymer platform technology is made to offer customized active packaging systems designed to meet the drug developer’s specific formulation as well as provide a broad spectrum of drug-specific protection.
Aptar CSP Technologies: Moisture Adsorption and Oxygen Scavenging Packaging System
Oxygen scavenging and moisture adsorption system added to Aptar CSP Technologies’ 3-phase Activ-Polymer platform technology portfolio.
Feb 7th, 2020
Aptar Pharma will showcase their broad portfolio of drug delivery solutions at Pharmapack 2020
Aptar Pharma to Highlight Drug Delivery Solutions Portfolio and Expanded Services Offering at Pharmapack 2020
Jan 16th, 2020
Xcelerate optimizes the active packaging development process through end-to-end insight and expedites speed-to-market.
Aptar CSP: Xcelerate Development Services to Fast-Track Active Packaging Systems
From stability challenge to commercial launch, Xcelerate expedites the packaging process for medicines sensitive to moisture, oxygen, and volatile compounds.
Nov 27th, 2019
Stevanato Inspection
Competitive Drugs Demand Innovative Delivery Devices
Vial and syringe might be fine if you’re the only game in town. But as competition grows, so does the demand to make drug delivery easier and more convenient for patients. In many cases, your best bet is to partner for that innovation.
Oct 29th, 2019